Alphageneron

Alphageneron Pharmaceuticals is a clinical-stage biopharmaceutical company developing autologous and allogeneic Natural Killer cells (NK) cell and antibody-based therapies to treat cancer. Our seasoned team of biopharmaceutical executives, scientists and clinicians in the United States and Europe, which brings decades of experience in translational cancer therapeutics, is integral to the success of our company.